Castleark Management’s BioTelemetry, Inc. BEAT Stock Holding History

Castleark Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-65,278	Closed	-$4.09M	–	428
2019 Q1	$4.09M	Sell	65,278 -150,033	-70%	-$10.3M	0.15%	168
2018 Q4	$12.9M	Sell	215,311 -89,995	-29%	-$5.4M	0.55%	43
2018 Q3	$19.7M	Buy	305,306 +585	+0.2%	+$32.6K	0.57%	41
2018 Q2	$13.7M	Buy	+304,721	New	+$12.2M	0.42%	74
2017 Q4	–	Sell	-437,527	Closed	-$14.4M	–	457
2017 Q3	$14.4M	Buy	437,527 +84,580	+24%	+$2.93M	0.45%	64
2017 Q2	$11.8M	Buy	+352,947	New	+$10.5M	0.39%	77

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Castleark Management's BEAT Position: Q2 2019 in Review

Castleark Management sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 65,278 shares — an estimated $4.09M sold.

Castleark Management first reported a position in BEAT in Q2 2017 and held it in 6 quarters. The position peaked at $19.7M in Q3 2018. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

Castleark Management reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
Castleark Management sold 65,278 BioTelemetry, Inc. shares in Q2 2019, an estimated $4.09M.
Castleark Management first reported a position in BioTelemetry, Inc. in Q2 2017 and held it in 6 quarters.
Castleark Management's BioTelemetry, Inc. position peaked at $19.7M in Q3 2018.
251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on Castleark Management's 13F filing for Q2 2019, filed 13 Aug 2019.